InvestorsHub Logo
icon url

birzinho

06/02/14 8:32 AM

#28551 RE: HDGabor #28547

Ok, HDG!
Everything is clear now (except what we're not allowed to know, of course). Thanks again.
Hoping we'll have some sign the SenateCommitee/FDA issue has been widerly known. Have a nice day
B.
icon url

jessellivermore

06/02/14 10:56 AM

#28554 RE: HDGabor #28547

HD my understanding...of default.

a) Amarin not pay on due date (every February, May, August, November) and within 30 days after written notice thereof is given by BioPharma;...

I believe the above statement is inncorrect. My read is if they do not make a required payment, then they are charged interest until 2017.

2.4 INTEREST. In the event a payment under this Agreement is not made when due hereunder, the amount of such outstanding payment will accrue interest (from the date such payment is due through and including the date on which full payment is made) at an annual rate equal to [***]. Payment of accrued interest will accompany payment of the outstanding payment.

Amarin is bound to an "open kimono" agreement. It must give provide complete disclosure..

Do not understand the liability issue..seems too remote..and likely to relate to lawsuits from third parties.

Basically my read is a default essentially refers only to them declaring bankruptcy.

JMHO...":>) JL